Unveiling the Metabolomic Profile of Oily Sensitive Skin: A Non-Invasive Approach

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2024 Oct 26

PMID 39456816

Authors

Jiaqi Zhang

Fan Wu

Jun Wang

Yi Qin

Yao Pan

Affiliations

Soon will be listed here.

Abstract

Skin barrier impairment is becoming increasingly common due to changes in lifestyle and modern living environments. Oily sensitive skin (OSS) is a condition that is characterized by an impaired skin barrier. Thus, examining the differences between OSS and healthy skin will enable a more objective evaluation of the characteristics of OSS and facilitate investigations of potential treatments. Initially, a self-assessment questionnaire was used to identify patients with OSS. Biophysical measurements and LAST scores were used to determine whether skin barrier function was impaired. Epidermal biophysical properties, including skin hydration, transepidermal water loss (TEWL), sebum content, erythema index (EI), and a* value, were measured with noninvasive instruments. We subsequently devised a noninvasive D-square sampling technique to identify changes in the skin metabolome in conjunction with an untargeted metabolomics analysis with an Orbitrap Q ExactiveTM series mass spectrometer. In the stratum corneum of 47 subjects, 516 skin metabolites were identified. In subjects with OSS, there was an increase in the abundance of 15 metabolites and a decrease in the abundance of 48 metabolites. The participants with OSS were found to have the greatest disruptions in sphingolipid and amino acid metabolism. The results revealed that an impaired skin barrier is present in patients with OSS and offers a molecular target for screening for skin barrier damage.

References

Stander S, Schneider S, Weishaupt C, Luger T, Misery L . Putative neuronal mechanisms of sensitive skin. Exp Dermatol. 2009; 18(5):417-23. DOI: 10.1111/j.1600-0625.2009.00861.x. View

Matwiejuk M, Mysliwiec H, Lukaszuk B, Lewoc M, Malla H, Mysliwiec P . The Interplay between Bioactive Sphingolipids in the Psoriatic Skin and the Severity of the Disease. Int J Mol Sci. 2023; 24(14). PMC: 10378918. DOI: 10.3390/ijms241411336. View

Jia Y, Gan Y, He C, Chen Z, Zhou C . The mechanism of skin lipids influencing skin status. J Dermatol Sci. 2017; 89(2):112-119. DOI: 10.1016/j.jdermsci.2017.11.006. View

Wen B, Mei Z, Zeng C, Liu S . metaX: a flexible and comprehensive software for processing metabolomics data. BMC Bioinformatics. 2017; 18(1):183. PMC: 5361702. DOI: 10.1186/s12859-017-1579-y. View

Kleuser B, Japtok L . Sphingolipids and inflammatory diseases of the skin. Handb Exp Pharmacol. 2013; (216):355-72. DOI: 10.1007/978-3-7091-1511-4_18. View

Dash P, Hergenroeder G, Jeter C, Choi H, Kobori N, Moore A . Traumatic Brain Injury Alters Methionine Metabolism: Implications for Pathophysiology. Front Syst Neurosci. 2016; 10:36. PMC: 4850826. DOI: 10.3389/fnsys.2016.00036. View

Diogo L, Papoila A . Is it possible to characterize objectively sensitive skin?. Skin Res Technol. 2010; 16(1):30-7. DOI: 10.1111/j.1600-0846.2009.00404.x. View

Baroni A, Buommino E, De Gregorio V, Ruocco E, Ruocco V, Wolf R . Structure and function of the epidermis related to barrier properties. Clin Dermatol. 2012; 30(3):257-62. DOI: 10.1016/j.clindermatol.2011.08.007. View

Miao H, Bai Y, Shen S, Chu M, Miao C, Yang J . Biological agent exerts therapeutic effects by reversing abnormalities in amino acid metabolic pathways in psoriasis. Exp Dermatol. 2024; 33(3):e15059. DOI: 10.1111/exd.15059. View

10.

Mound A, Lozanova V, Warnon C, Hermant M, Robic J, Guere C . Non-senescent keratinocytes organize in plasma membrane submicrometric lipid domains enriched in sphingomyelin and involved in re-epithelialization. Biochim Biophys Acta Mol Cell Biol Lipids. 2017; 1862(9):958-971. DOI: 10.1016/j.bbalip.2017.06.001. View

11.

Kang H, Li X, Zhou Q, Quan C, Xue F, Zheng J . Exploration of candidate biomarkers for human psoriasis based on gas chromatography-mass spectrometry serum metabolomics. Br J Dermatol. 2016; 176(3):713-722. DOI: 10.1111/bjd.15008. View

12.

Brandwein M, Gamrasni K, Landau T, Bauer-Rusek S, Smolkin T . Nurture, not nature: Impaired skin barrier in infants born to urban households. Pediatr Allergy Immunol. 2022; 33(10):e13868. DOI: 10.1111/pai.13868. View

13.

Bhattacharya N, Sato W, Kelly A, Ganguli-Indra G, Indra A . Epidermal Lipids: Key Mediators of Atopic Dermatitis Pathogenesis. Trends Mol Med. 2019; 25(6):551-562. PMC: 6698381. DOI: 10.1016/j.molmed.2019.04.001. View

14.

Wu Y, Wang X, Zhou Y, Tan Y, Chen D, Chen Y . Correlation between stinging, TEWL and capacitance. Skin Res Technol. 2003; 9(2):90-3. DOI: 10.1034/j.1600-0846.2003.00026.x. View

15.

Ishikawa J, Narita H, Kondo N, Hotta M, Takagi Y, Masukawa Y . Changes in the ceramide profile of atopic dermatitis patients. J Invest Dermatol. 2010; 130(10):2511-4. DOI: 10.1038/jid.2010.161. View

16.

Martinez Y, Li X, Liu G, Bin P, Yan W, Mas D . The role of methionine on metabolism, oxidative stress, and diseases. Amino Acids. 2017; 49(12):2091-2098. DOI: 10.1007/s00726-017-2494-2. View

17.

Madnani N, Deo J, Dalal K, Benjamin B, Murthy V, Hegde R . Revitalizing the skin: Exploring the role of barrier repair moisturizers. J Cosmet Dermatol. 2024; 23(5):1533-1540. DOI: 10.1111/jocd.16171. View

18.

Feingold K, Elias P . Role of lipids in the formation and maintenance of the cutaneous permeability barrier. Biochim Biophys Acta. 2013; 1841(3):280-94. DOI: 10.1016/j.bbalip.2013.11.007. View

19.

Zhang X, Tao H, Deng Y, He X, Zhang Z, Zhong L . Efficacy and safety of a panthenol-enriched mask for individuals with distinct impaired skin barrier subtypes. J Cosmet Dermatol. 2024; 23(6):2109-2116. DOI: 10.1111/jocd.16231. View

20.

Chen Y, Lu H, Hou P, Lin Y, Aala W, Onoufriadis A . Plasma metabolomic profiling reflects the malnourished and chronic inflammatory state in recessive dystrophic epidermolysis bullosa. J Dermatol Sci. 2022; 107(2):82-88. DOI: 10.1016/j.jdermsci.2022.07.006. View